References
1- Feldstein L.R., Rose E.B., Horwitz S.M. et al, Multisystem Inflammatory Syndrome in U.S. Children and Adolescents N Engl J Med 2020;383:334-46. DOI: 10.1056/NEJMoa2021680
2- Zhou MY, Xiao-Li Xie XL, Peng YG. From SARS to COVID-19: What we have learned about children infected with COVID-19. IJID 2020; 96: 710-714 https://doi.org/10.1016/j.ijid.2020.04.090
3- de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandão MB. Clinical manifestations of children with COVID‐19: A systematic review. Pediatric Pulmonology.
2020;1–8. https://doi.org/10.1002/ppul.24885
4- Bhopal S, Bagaria J, Bhopal R. Children’s mortality from COVID-19 compared with all-deaths and other relevant causes of death: epidemiological information for decision-making by parents, teachers, clinicians and policymakers. Public Health 2020 doi:10.1016/j.puhe.2020.05.047
5- Wu H, Zhu H, Yuan C. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) inWuhan, China
,JAMA Network Open. 2020;3(6):e2010895. doi:10.1001/jamanetworkopen.2020.10895 (
6- Maharaj AR, Wu H, Hornik CP, et al. Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019. JAMA Pediatr. Published online June 05, 2020. doi:10.1001/jamapediatrics.2020.2422
7- Isaacs D, Britton PN, Preisz A. Ethical reflections on the COVID-19 pandemic: The epidemiology of panic. J Paeditr Child Health 2020; 56:690-1 doi:10.1111/jpc.14882
8- Hwang TJ, Randolph AG, Bourgeouis FT. Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19) JAMA Pediatrics 2020 Published Online:May 7, 2020. doi:10.1001/jamapediatrics.2020.1888
9- Gwee A, Boast A, Osowicki J, et al. Paediatric treatment trials for COVID-19 are an ethical imperative Arch Dis Child 2020;0:1. doi:10.1136/archdischild-2020-319701